These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23177972)
1. Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice. Fujisaka T; Hoshiga M; Hotchi J; Takeda Y; Jin D; Takai S; Hanafusa T; Ishizaka N Atherosclerosis; 2013 Jan; 226(1):82-7. PubMed ID: 23177972 [TBL] [Abstract][Full Text] [Related]
2. I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice. He S; Nian F; Chen W; Yin L; Auchoybur ML; Tao Z; Tang S; Chen X Biomed Pharmacother; 2019 Jan; 109():1287-1295. PubMed ID: 30463808 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357 [TBL] [Abstract][Full Text] [Related]
4. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Cassis LA; Gupte M; Thayer S; Zhang X; Charnigo R; Howatt DA; Rateri DL; Daugherty A Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1660-5. PubMed ID: 19252100 [TBL] [Abstract][Full Text] [Related]
5. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice. Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M Atherosclerosis; 2009 Jun; 204(2):359-64. PubMed ID: 18996524 [TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880 [TBL] [Abstract][Full Text] [Related]
7. Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice. Jiang F; Jones GT; Dusting GJ Br J Pharmacol; 2007 Nov; 152(6):880-90. PubMed ID: 17828285 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm. Wei Z; Wang Y; Zhang K; Liao Y; Ye P; Wu J; Wang Y; Li F; Yao Y; Zhou Y; Liu J Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2429-38. PubMed ID: 25234817 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice. Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482 [TBL] [Abstract][Full Text] [Related]
11. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772 [TBL] [Abstract][Full Text] [Related]
12. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738 [TBL] [Abstract][Full Text] [Related]
13. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II]. ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653 [TBL] [Abstract][Full Text] [Related]
14. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice. Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951 [TBL] [Abstract][Full Text] [Related]
15. Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model. Seto SW; Krishna SM; Moran CS; Liu D; Golledge J Clin Sci (Lond); 2014 Jul; 127(2):123-34. PubMed ID: 24476071 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice. Wang YX Neurobiol Aging; 2005 Mar; 26(3):309-16. PubMed ID: 15639308 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. Arishiro K; Hoshiga M; Negoro N; Jin D; Takai S; Miyazaki M; Ishihara T; Hanafusa T J Am Coll Cardiol; 2007 Apr; 49(13):1482-9. PubMed ID: 17397679 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. Cao RY; Adams MA; Habenicht AJ; Funk CD Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):34-42. PubMed ID: 17643886 [TBL] [Abstract][Full Text] [Related]